Oncolytics Biotech
ONCY
$1.19
Share price
0.85%
Change (1 day)
-30.41%
Change (1 year)
Categories
Oncolytics Biotech (ONCY) - Net assets
Net assets on the balance sheet as of December 2023 : $20.81 M
According to Oncolytics Biotech
's latest financial reports the company has $20.81 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Oncolytics Biotech - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $20.81 M | 6.27% |
| 2022-12-31 | $19.59 M | -30.84% |
| 2021-12-31 | $28.32 M | 45.91% |
| 2020-12-31 | $19.41 M | -23599.55% |
| 2019-12-31 | $-0.09 M | -101.82% |
| 2018-12-31 | $4.54 M | -30.93% |
| 2017-12-31 | $6.58 M | -17.25% |
| 2016-12-31 | $7.95 M | -55.26% |
| 2015-12-31 | $17.78 M | 49.37% |
| 2014-12-31 | $11.9 M | -42.93% |
| 2013-12-31 | $20.86 M | 40.33% |
| 2012-12-31 | $14.87 M | -48.58% |
| 2011-12-31 | $28.91 M | -31.07% |
| 2010-12-31 | $41.94 M | 40.72% |
| 2009-12-31 | $29.81 M | 283.43% |
| 2008-12-31 | $7.77 M | -66.96% |
| 2007-12-31 | $23.53 M | -11.04% |
| 2006-12-31 | $26.45 M | -30.67% |
| 2005-12-31 | $38.15 M | 19.38% |
| 2004-12-31 | $31.96 M | 65.74% |
| 2003-12-31 | $19.28 M | 59.39% |
| 2002-12-31 | $12.09 M | 3.79% |
| 2001-12-31 | $11.65 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Eli Lilly LLY | $12.89 B | 61,849.55% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $16.54 B | 79,384.32% | 🇺🇸 USA |
 Mirati Therapeutics MRTX | $0.94 B | 4,446.12% | 🇺🇸 USA |
 Aeterna Zentaris AEZS | $18.19 M | -12.60% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $8.12 B | 38,931.28% | 🇮🇱 Israel |
 AVEO Oncology
AVEO | $28.84 M | 38.55% | 🇺🇸 USA |